Platinum-Montaur Life Sciences, LLC
Insider CIK 1404598 · ECTE 10% owner · DLYT.OB 10% owner · NAVB 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ECTE Echo Therapeutics, Inc. | J Other deriv | 2014-12-18 | 2015-05-18 | 447,590 | — | $0 | 447,590 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2014-12-18 | 2015-05-18 | 420,168 | $1.19 | $500.0K | 420,168 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2014-12-18 | 2015-05-18 | 1 | — | $0 | 1 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | J Other deriv | 2014-12-18 | 2015-05-18 | 1,052,410 | — | $0 | 1,472,578 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | J Other | 2014-12-18 | 2015-05-18 | 447,590 | — | $0 | 272,603 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | J Other | 2014-12-18 | 2015-05-18 | 1,052,410 | — | $0 | 511,273 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2014-12-18 | 2014-12-22 | 1 | — | $0 | 1 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2014-12-18 | 2014-12-22 | 420,168 | $1.19 | $500.0K | 420,168 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2014-09-02 | 2014-09-04 | 60,000 | $1.36 | $81.6K | 14,946,431 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2014-06-30 | 2014-07-01 | 55,083 | $2.20 | $121.2K | 678,452 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2014-06-27 | 2014-07-01 | 10,656 | $2.20 | $23.4K | 623,369 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2014-06-26 | 2014-06-27 | 15,000 | $2.20 | $33.0K | 612,713 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2014-06-25 | 2014-06-27 | 2,300 | $2.20 | $5.1K | 597,713 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2014-06-24 | 2014-06-24 | 386 | $2.20 | $849 | 595,413 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2014-06-23 | 2014-06-24 | 85 | $2.20 | $187 | 595,027 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2014-06-20 | 2014-06-24 | 16,490 | $2.20 | $36.3K | 594,942 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2013-12-10 | 2013-12-12 | 1 | — | $0 | 1 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2013-12-10 | 2013-12-12 | 1,398,890 | $2.75 | $3.85M | 1,398,890 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2013-12-10 | 2013-12-12 | 349,723 | $2.75 | $961.7K | 349,723 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy deriv | 2013-12-10 | 2013-12-12 | 1 | — | $0 | 1 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2013-12-10 | 2013-12-12 | 13,914 | $2.75 | $38.3K | 578,452 | SEC↗ |
| ECTE Echo Therapeutics, Inc. | P Buy | 2013-12-10 | 2013-12-12 | 55,655 | $2.75 | $153.1K | 507,824 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | J Other | 2012-11-27 | 2012-11-29 | 3,001,860 | $2.58 | $7.74M | 3,799,156 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | P Buy | 2012-10-10 | 2012-11-09 | 37,030 | $2.56 | $94.8K | 6,801,016 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-21 | 2012-11-09 | 4,911 | $3.24 | $15.9K | 6,763,986 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-19 | 2012-11-09 | 21,700 | $3.22 | $69.9K | 6,768,897 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-10 | 2012-11-09 | 269,919 | $3.69 | $996.0K | 6,790,597 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-10 | 2012-11-09 | 20,500 | $3.75 | $76.9K | 7,060,516 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-07 | 2012-11-09 | 118,731 | $3.61 | $428.6K | 7,081,016 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-06 | 2012-11-09 | 2,200 | $3.71 | $8.2K | 7,199,747 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-05 | 2012-11-09 | 64,900 | $3.78 | $245.3K | 7,201,947 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | S Sale | 2012-09-04 | 2012-11-09 | 205,521 | $3.80 | $781.0K | 7,266,847 | SEC↗ |